Riskpilot← Back to searchSign inGet full accessLISEAPOTEKENE AS
ASActiveOrg 988839450Sundveien 15A, 1397 NesøyaRetail sale of pharmaceutical products · NACE 4773Est. 20050 employees
Revenue 2020
NOK 42,7M
+10% vs 2019
EBITDA margin
7.1%
+78% vs 2019
Equity ratio
13.0%
Financial strength
Net profit 2020
NOK 2,3M
+97% vs 2019
| Revenue | NOK 42,7M | +10% |
| EBITDA | NOK 3M | +78% |
| Net profit | NOK 2,3M | +97% |
| Total assets | NOK 9,9M | +18% |
| Equity | NOK 1,3M | -14% |
| Employees | 0 | — |
Legal name
LISEAPOTEKENE AS
Org number
988839450
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
8. november 2005
Share capital
NOK 73 639 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Ordinær apotekdrift samt salg av kompetanse og løsninger innen apotekdrift.
Address
Sundveien 15A, 1397 Nesøya
Phone
+4766847010
Email
sandvika@liseapotekene.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 31 487 | 34 642 | 36 661 | 38 989 | 42 735 |
| Staff expenses | −6 940 | −6 649 | −6 889 | −7 487 | −7 857 |
| EBITDA | −204 | 731 | 1 958 | 1 699 | 3 027 |
| Depreciation & amort. | −202 | −242 | −240 | −223 | −96 |
| EBIT | −406 | 489 | 1 717 | 1 477 | 2 931 |
| Net financials | −3 | 1 | −2 | 15 | 12 |
| Profit before tax | −409 | 489 | 1 715 | 1 491 | 2 942 |
| Tax | −91 | 260 | 258 | 329 | 649 |
| Net profit | −318 | 230 | 1 457 | 1 163 | 2 294 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 5 702 | 7 102 | 8 385 | 8 431 | 9 927 |
| Equity | 1 004 | 1 534 | 1 591 | 1 500 | 1 294 |
| Long-term debt | 0 | 0 | 18 | 0 | 0 |
| Short-term debt | 4 697 | 5 568 | 6 776 | 6 931 | 8 633 |
| Total debt | 4 697 | 5 568 | 6 794 | 6 931 | 8 633 |
EBITDA margin
7.1%
This company
15.8%
Market median
-55% vs market
20162020
Equity ratio
13.0%
This company
38.2%
Market median
-66% vs market
20162020
Return on equity
177.3%
This company
18.4%
Market median
+864% vs market
20162020
Net profit margin
5.4%
This company
8.1%
Market median
-33% vs market
20162020
Asset turnover
4.31×
This company
1.12×
Market median
+285% vs market
20162020
Debt / equity
6.67×
This company
0.62×
Market median
-976% vs market
20162020
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
LS Deputy Member | Deputy Member | 2016 – 2021 |
PO Deputy Member | Deputy Member | 2016 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Former (3) | ||
| Chairman | 2016 – 2021 | |
| Board of Directors | 2016 – 2021 | |
| Board of Directors | 2016 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LISEAPOTEKENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lene Strand | Deputy Member | 0 companies |
| Per Ola Andfossen | Deputy Member | 0 companies |
| Vegard Hoff | Board of Directors | 0 companies |
| Lise Ekroll Aarvold | Chairman | 0 companies |
| Terje Kvaal | Board of Directors | 0 companies |
| Øystein Aarvold | Board of Directors | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |